On this HVAD, our colleagues share perspectives on how an HIV vaccine can be developed with the people it seeks to benefit most.
Features
This test sensitively quantifies diverse strains of HIV to advance vaccine and cure research.
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board of directors.
March 17, 2022
HVTN, NIAID, and Moderna partner on trial of HIV Env trimers designed by IAVI's William Schief.
February 17, 2022
New TB vaccines are our best hope for a world without TB — it’s time to step up and finally make them a reality.
February 9, 2022
Using the power of social media to illuminate the urgent need for sustainable TB vaccine R&D
January 5, 2022
The archbishop advocated for the human rights of people living with HIV and tuberculosis
November 10, 2021
Strengthening research and science leadership capacity of African researchers
October 20, 2021
The call is endorsed by a global coalition advocating for a fully funded and resourced TB vaccine pipeline by 2023
October 18, 2021
IAVI and African Vaccine Manufacturing Initiative host virtual forum
September 30, 2021
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board since 2018.
Show More
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
